Condition

Thymoma

ClinicalTrials.gov condition label

Clinical trials15

Recruiting1

Common interventions17

Lead sponsors shown12

Clinical trials

15 shown

Tissue Procurement and Natural History Study of Patients With Malignant MesotheliomaNCT01950572 · 2013-09-09

Depressive Tendency and Counseling Outcomes in Thymoma-Associated MGNCT07649187 · 2024-01-01

Clinical Investigation of the da Vinci Surgical SystemNCT05682742 · 2022-12-12

ACTIVE_NOT_RECRUITING

SP Thoracic IDE StudyNCT05150210 · 2022-07-20

ACTIVE_NOT_RECRUITING

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic CancersNCT04072393 · 2021-01-15

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid TumorsNCT03023319 · 2019-12-10

A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsNCT03517488 · 2018-07-10

Confocal Laser Endomicroscopy in Pleural MalignanciesNCT03290183 · 2017-08-28

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based ChemotherapyNCT03076554 · 2017-04-19

ACTIVE_NOT_RECRUITING

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without ChemotherapyNCT02062632 · 2014-04-14

Molecular Analysis of Thoracic MalignanciesNCT01385722 · 2011-08-01

ENROLLING_BY_INVITATION

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesNCT01242072 · 2010-12-01

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasNCT01258868 · 2010-12-01

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic MalignanciesNCT00921739 · 2009-09-11

Nonmyeloablative Allogeneic TransplantNCT01272817 · 2001-10-01

Common interventions

Robotic-assisted SurgeryDEVICE2 AvelumabDRUG1 BosutinibDRUG1 CelebrexDRUG1 Confocal laser endomicroscopyDEVICE1 Doxepin HydrochlorideDRUG1 Esophageal sparing IMRTRADIATION1 Home-based cardiac rehabilitationPROCEDURE1 Nonmyeloablative Allogeneic TransplantPROCEDURE1 palifosfamide-trisDRUG1 PemetrexedDRUG1 PlaceboOTHER1 Psychological counseling interventionBEHAVIORAL1 Quality-of-Life AssessmentOTHER1 Questionnaire AdministrationOTHER1 Tumor cell vaccineBIOLOGICAL1 XmAb20717BIOLOGICAL1

Leading sponsors

National Cancer Institute (NCI)3 Intuitive Surgical2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Alaunos Therapeutics1 Duke University1 Mayo Clinic1 Ming-Hsing Chang1 Nagla Abdel Karim1 Scripps Health1 Stanford University1 Washington University School of Medicine1 Xencor, Inc.1

Trial status mix

COMPLETED6

ACTIVE_NOT_RECRUITING3

TERMINATED3

ENROLLING_BY_INVITATION1

RECRUITING1

UNKNOWN1

Phase mix

NA5

PHASE15

PHASE22

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.